CAS RN: 1845-11-0
Nafoxidine
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 1 grade group
Grade
Moligand™, ≥99% (3)
In stock only
Batch No. Package Availability Inquiry
Batchno.20250906
100mg
In stock
Inquiry
Batchno.20260401
25mg
In stock
Inquiry
Batchno.20250303
5mg
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1845-11-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1845-11-0 / 1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine
Standard CAS: 1845-11-0
Multi CAS: No
Basic Information
copy
CAS
1845-11-0 copy
Multi CAS
No copy
Molecular Formula
C29H31NO2 copy
Molecular Weight
425.600000 copy
Exact Mass
425.235479 copy
SMILES
COC1=CC2=C(C=C1)C(=C(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)OCCN5CCCC5 copy
InChI
InChI=1S/C29H31NO2/c1-31-26-14-16-28-24(21-26)11-15-27(22-7-3-2-4-8-22)29(28)23-9-12-25(13-10-23)32-20-19-30-17-5-6-18-30/h2-4,7-10,12-14,16,21H,5-6,11,15,17-20H2,1H3 copy
InChIKey
JEYWNNAZDLFBFF-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
32 copy
Aromatic heavy atom count
18 copy
Fraction Csp3
0.31 copy
Rotatable bonds
7 copy
H-bond acceptors
3 copy
Molar refractivity
131.28 copy
TPSA
21.7 copy
LogP / Solubility
WLOGP
6.08 copy
MLOGP
5.37 copy
XLogP3
5.8 copy
Consensus LogP
5.75 copy
Log S (ESOL)
-6.26 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-7.44 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-8.31 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
3.5 copy
Safety & Transport
copy
Pictogram(s)
Health Hazard copy
Signal
Warning copy
GHS Hazard Statements
H351 (100%): Suspected of causing cancer [Warning Carcinogenicity]
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] copy
Precautionary Statement Codes
P203, P280, P318, P405, and P501 copy